Association of Plasminogen Activator Inhibitor-1 4G/5G and Angiotensin-Converting Enzyme I/D Polymorphisms with Recurrent Pregnancy Loss in Sudanese Women: A Case-Control study

Association of Plasminogen Activator Inhibitor-1 4G/5G and Angiotensin-Converting Enzyme I/D Polymorphisms with Recurrent Pregnancy Loss in Sudanese Women: A Case-Control study

The aim of our study was to investigate the relationship between the ACE I/D and PAI-1 4G/5G polymorphisms and RPL in Sudanese women. Methods and Results: A total of 232 people participated in this case-control study, including 119 women who had been diagnosed with RPL (Case group) and 113 healthy...

Full description

Bibliographic Details
Main Authors:	Hanan K. Ahmed, Amanda G. Elgoraish, Selma Elmalieh Abdalla, Asaad MA. Babker, Ayman Hussien Alfeel, Amin Omer Ibrahim Abbas, Khalid Abdelsamea Mohamedahmed, Salaheldein G Elzaki
Format:	Article
Language:	English
Published:	International Medical Research and Development Corporation 2023-03-01
Series:	International Journal of Biomedicine
Subjects:	angiotensin-converting enzyme plasminogen activator inhibitor-1 recurrent pregnancy loss
Online Access:	http://www.ijbm.org/articles/i49/ijbm_13(1)_oa18.pdf

Similar Items

Strong association between angiotensin I-converting enzyme insertion/deletion polymorphism and unexplained recurrent spontaneous abortion of Sudanese women: a case-control study
by: Asaad M.A. Babker, et al.
Published: (2024-04-01)

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T Mutations among Sudanese Women with Recurrent Pregnancy Loss
by: Asaad Ma. Babker, et al.
Published: (2024-03-01)

Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014-10-01)

Plasminogen interaction with Trypanosoma cruzi
by: Laura Almeida, et al.
Published: (2004-02-01)

Point Mutation in Factor V Leiden G1691A and Factor II G20210A and Effect on Coagulation Profile and Frequency of Recurrent Spontaneous Abortions among Sudanese Women
by: Asaad Mohammed Ahmed Abd Allah Babker , Fath Elrahman Mahdi Hassan Gameel , Salaheldein Gumaa Elzaki , 4 5 6 Amanda G Elgoraish , Lienda Bashier Eltayeb , Hisham Ali Waggiallah
Published: (2016-09-01)

ISOLATION AND PURIFICATION OF A KRINGLE 5 FROM HUMAN PLASMINOGEN USING AH-SEPHAROSE
by: Kapustianenko L. G., et al.
Published: (2014-08-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Hemostasis System and Plasminogen Activity in Retrochorial Hematoma in the First Trimester of Pregnancy
by: Natalia B. Tikhonova, et al.
Published: (2022-09-01)

The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough
by: Rui Tang, et al.
Published: (2023-02-01)

Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension
by: Wang Z, et al.
Published: (2023-04-01)

PRODUCTION AND CHARACTERISTICS OF ANTIBODIES AGAINST K1-3 FRAGMENT OF HUMAN PLASMINOGEN
by: A. A. Tykhomyrov, et al.
Published: (2013-02-01)

Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease
by: Teresa Brito-Robinson, et al.
Published: (2024-06-01)

Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease
by: Breanne H.Y. Gibson, et al.
Published: (2020-05-01)

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
by: Jason S. Palazzolo, et al.
Published: (2022-07-01)

Plasminogen Activator – Multifunctional Protein of Plague Pathogen
by: L. M. Kukleva, et al.
Published: (2016-09-01)

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-01-01)

Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update
by: Mohaddese Maghsudlu, et al.
Published: (2024-05-01)

Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions
by: Carla Samily de Oliveira Costa, et al.
Published: (2022-05-01)

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-03-01)

Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure
by: Matthieu Lépine, et al.
Published: (2022-10-01)

Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression
by: Nayela N. Chowdhury, et al.
Published: (2024-01-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1
by: Charles Nakar, et al.
Published: (2024-09-01)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
by: Nurbadriah binti Jasmiad, et al.
Published: (2022-09-01)

P1559: ASSOCIATION BETWEEN TNF-Α LEVELS AND FALCIPARUM MALARIA PANCYTOPENIA AMONG SUDANESE CHILDREN
by: Khalid Abdelsamea Mohamedahmed
Published: (2023-08-01)

POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN KRINGLE 5
by: Kapustianenko L. G.
Published: (2017-06-01)

Tissue plasminogen activator-assisted surgical removal of massive subretinal hemorrhage
by: G Mahesh, et al.
Published: (2020-01-01)

Evaluation of obstacles to receive tissue plasminogen activator in patients with acute ischemic stroke in Imam Khomeini Hospital of Urmia
by: Hamidreza Mehryar, et al.
Published: (2024-01-01)

The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt
by: Ahmed Farouk Donia, et al.
Published: (2017-12-01)

PLASMINOGEN ACTIVATOR OF YERSINIA PESTIS
by: V. V. Evseeva, et al.
Published: (2015-04-01)

Study of common chromosomal abnormalities and Plasminogen activator Inhibitor(PAI-1) gene Polymorphism (5G/4G) and Prothrombin (F2)gene mutation(G20210A) in women with recurrent abortions in the North West of Iran
by: Roya Bagheri, et al.
Published: (2021-12-01)

Evaluation of the biological activation of plasmin plasminogen system in sheep and goat milk
by: A. Baldi, et al.
Published: (2010-01-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Assessment of serum levels of homocysteine, Ang 1-7, and plasminogen activator Inhibitor-1 protein in samples of coronavirus disease 2019 patients in Iraq
by: Ghazwan Faisal Hussein, et al.
Published: (2023-01-01)

Association between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms
Published: (2013-09-01)

Effects of Ghrelin on Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells
by: Elisabetta Fiacco, et al.
Published: (2024-01-01)

A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
by: Kemal Erdinç, et al.
Published: (2013-09-01)

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
by: Yukihiro Yoneda, et al.
Published: (2009-06-01)

Determination of plasminogen/plasmin system components and indicators of lipoproteins oxidative modification under arterial hypertension
by: O. I. Yusova, et al.
Published: (2018-02-01)

Type I plasminogen deficiency with unexpected clinical aspects: Could be more than coexistence?
by: Şule Altıner, et al.
Published: (2017-01-01)